QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

CSBR: 59% | Champions Oncology shares are trading higher after the company reported better-than-expected Q1 financial results. ...

 craig-hallum-upgrades-champions-oncology-to-buy-maintains-price-target-to-6

Craig-Hallum analyst Matt Hewitt upgrades Champions Oncology (NASDAQ:CSBR) from Hold to Buy and maintains the price target f...

 champions-oncology-q1-adj-011-beats-003-estimate-sales-1406m-beat-1323m-estimate

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(...

 champions-oncology-q4-2024-adj-eps-001-beats-016-estimate-sales-14001m-beat-12692m-estimate

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(...

 craig-hallum-downgrades-champions-oncology-to-hold

Craig-Hallum analyst Matt Hewitt downgrades Champions Oncology (NASDAQ:CSBR) from Buy to Hold.

 champions-oncology-q3-adj-016-misses-015-estimate-sales-1202m-miss-1348m-estimate

Champions Oncology (NASDAQ:CSBR) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of ...

 earnings-scheduled-for-march-12-2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

 insiders-buying-solid-biosciences-and-2-other-stocks

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.

 insiders-buying-tillys-and-2-other-stocks

Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.

 champions-oncology-revises-fiscal-year-2024-revenue-guidance-to-be-generally-in-line-with-last-years-results

David Miller, CFO of Champions, added, "As we've guided over the last several quarters, the increase in study cancellat...

 champions-oncology-q2-eps-015-down-from-001-yoy-sales-1160m-down-from-1428m-yoy

Champions Oncology (NASDAQ:CSBR) reported quarterly losses of $(0.15) per share. This is a 1600 percent decrease over earnings ...

 earnings-scheduled-for-december-12-2023

Companies Reporting Before The Bell • CSP (NASDAQ:CSPI) is likely to report earnings for its fourth quarter.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION